The global healthcare industry is witnessing increasing demand for advanced supportive oncology therapies as cancer treatment volumes continue to rise worldwide. Among the most critical areas of focus is the management of chemotherapy-induced neutropenia (CIN), a potentially life-threatening condition that can compromise treatment effectiveness and patient safety. As healthcare providers seek...